Skip to main content
OpenTrials

Clinical trial condition

Systemic Lupus Erythematosus

Explore clinical trials studying Systemic Lupus Erythematosus. Study availability and eligibility vary by location and protocol.

484 public trials 112 recruiting studies
Refine in advanced search Browse all conditions

Systemic Lupus Erythematosus trial results

Completed

A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus

NCT05856448

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • University of Arizona College of Medicine - Tucson Tucson, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Desert Medical Advances Rancho Mirage, California, United States
  • Millennium Clinical Trials Simi Valley, California, United States
View all 84 locations
View Trial Details
Completed

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

NCT04908865

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Beijing, China
  • GSK Investigational Site Changchun, China
  • GSK Investigational Site Changsha, China
  • GSK Investigational Site Chongqing, China
View Trial Details
Completed

JBT-101 in Systemic Lupus Erythematosus (SLE)

NCT03093402

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology La Jolla, California, United States
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View all 16 locations
View Trial Details
Completed

Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

NCT01649765

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Augusta, Georgia, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 32 locations
View Trial Details
Completed

Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

NCT01729455

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Glendale, Arizona, United States
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 179 locations
View Trial Details
Completed

Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus

NCT03920267

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0077 Birmingham, Alabama, United States
  • Local Institution - 0030 El Cajon, California, United States
  • Local Institution - 0049 Torrance, California, United States
  • Local Institution - 0074 New Haven, Connecticut, United States
View all 98 locations
View Trial Details

Related conditions